Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

NuPathe (NASDAQ:PATH.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PATH.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.78)
Submitted June 16, 2011

I caught one bottom on NuPathe last fall and missed another a couple of months ago. Now I'm betting on the stock to rise from the current 100M market cap in advance of the August 29 PDUFA for Zelrix. I'd better be right because I'm seeing a… More

zzlangerhans (99.78)
Submitted November 19, 2013

This red thumb could make me look dumb in the short term if NuPathe were to announce a Zecuity partnership, which certainly isn't outside the realm of possibility. Nevertheless, it's hard to imagine partnership terms which will change the fact that… More

NASDAQ:PATH.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PATH.DL.

No one has written a Pitch for PATH.DL stock yet. Tell us why you think PATH.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PATH.DL.

No players have picked PATH.DL yet. Tell us why you think PATH.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PATH.DL.